0001893825-22-000001.txt : 20221115 0001893825-22-000001.hdr.sgml : 20221115 20221115163916 ACCESSION NUMBER: 0001893825-22-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20221115 DATE AS OF CHANGE: 20221115 EFFECTIVENESS DATE: 20221115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nextech VII Oncology SCSp CENTRAL INDEX KEY: 0001893825 IRS NUMBER: 000000000 STATE OF INCORPORATION: N4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-421265 FILM NUMBER: 221391701 BUSINESS ADDRESS: STREET 1: 8, RUE LOU HEMMER CITY: SENNINGERBERG STATE: N4 ZIP: L - 1748 BUSINESS PHONE: 41 44 366 66 10 MAIL ADDRESS: STREET 1: 8, RUE LOU HEMMER CITY: SENNINGERBERG STATE: N4 ZIP: L - 1748 D/A 1 primary_doc.xml X0708 D/A LIVE 0001893825 Nextech VII Oncology SCSp 8, RUE LOU HEMMER SENNINGERBERG N4 LUXEMBOURG L - 1748 41 44 366 66 15 LUXEMBOURG None None Limited Partnership true 2021 N/A Nextech VII GP S.a r.l. 8, rue Lou Hemmer Senningerberg N4 LUXEMBOURG L-1748 Director General Partner of the Issuer Rocco J. Sgobbo c/o Nextech Invest AG Bahnhofstrasse 18 Zurich V8 SWITZERLAND CH-8001 Executive Officer Ian Charoub c/o Nextech VII GP S.a r.l. 8, rue Lou Hemmer Senningerberg N4 LUXEMBOURG L-1748 Executive Officer Dalia Bleyer c/o Nextech VII GP S.a r.l. 8, rue Lou Hemmer Senningerberg N4 LUXEMBOURG L-1748 Executive Officer Thilo Schroeder c/o Nextech Invest AG Bahnhofstrasse 18 Zurich V8 SWITZERLAND CH-8001 Executive Officer Jacob Loven c/o Nextech Invest AG Bahnhofstrasse 18 Zurich V8 SWITZERLAND CH-8001 Executive Officer Alfred Scheidegger c/o Nextech Invest AG Bahnhofstrasse 18 Zurich V8 SWITZERLAND CH-8001 Executive Officer Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.1 3C.7 true 0001893825-21-000001 2021-11-24 true true true false 0 Indefinite 235062500 Indefinite false 38 0 0 0 true The general partner or its designees are entitled to a carried interest and a management fee. The carried interest and management fee are fully disclosed in the Issuer's confidential offering materials. false Nextech VII Oncology SCSp Rocco Sgobbo Rocco Sgobbo Manager of the General Partner of the Issuer 2022-11-15